Skip to main content
. 2017 Feb;58(2):933–943. doi: 10.1167/iovs.16-19782

Figure 3.

Figure 3

Tumor necrosis factor-α and IL-6 levels in AGA-treated human macrophages after transfection with miR-146b-3p mimic or control miR (nontargeting miRNA). (A) Tumor necrosis factor-α level in human macrophages transfected with miR-146b-3p or control miR then treated with AGA. Tumor necrosis factor-α level was significantly reduced after transfection with miR-146b-3p compared with control miR (*P < 0.05 versus control miR group; n = 5–6). (B) Interleukin-6 level in human macrophages transfected with miR-146b-3p or control miR and then treated with AGA. Interleukin-6 level was significantly reduced after transfection with miR-146b-3p compared with control miR (*P < 0.05 versus control miR group; n = 4).